KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Times Interest Earned: 2017-2025

Historic Times Interest Earned for Arbutus Biopharma (ABUS) over the last 8 years, with Sep 2025 value amounting to -$376.48.

  • Arbutus Biopharma's Times Interest Earned rose 49.08% to -$376.48 in Q3 2025 from the same period last year, while for Sep 2025 it was -$429.39, marking a year-over-year increase of 22.01%. This contributed to the annual value of -$557.07 for FY2024, which is 227.38% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Times Interest Earned of -$376.48 as of Q3 2025, which was down 808.43% from $53.14 recorded in Q2 2025.
  • Over the past 5 years, Arbutus Biopharma's Times Interest Earned peaked at $53.14 during Q2 2025, and registered a low of -$917.82 during Q1 2025.
  • For the 3-year period, Arbutus Biopharma's Times Interest Earned averaged around -$423.22, with its median value being -$464.43 (2024).
  • Per our database at Business Quant, Arbutus Biopharma's Times Interest Earned plummeted by 1,028.81% in 2023 and then surged by 108.37% in 2025.
  • Over the past 5 years, Arbutus Biopharma's Times Interest Earned (Quarterly) stood at -$37.14 in 2021, then tumbled by 96.62% to -$73.02 in 2022, then crashed by 545.78% to -$471.52 in 2023, then grew by 1.50% to -$464.43 in 2024, then spiked by 49.08% to -$376.48 in 2025.
  • Its Times Interest Earned stands at -$376.48 for Q3 2025, versus $53.14 for Q2 2025 and -$917.82 for Q1 2025.